Clinical Trial Update: Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of Paroxetine CR and Quetiapine for refractory generalized anxiety disorder; results were posted after completion in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Paroxetine-CR (paroxetine)
• Quetiapine (quetiapine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-04-23